drug development

Podcast

Teva’s CEO shares ‘Pivot to Growth’ progress

In this episode of "The Top Line," Teva CEO Richard Francis shares progress on the company’s “Pivot to Growth” strategy and what lies ahead.

Ayla Ellison , Fraiser Kansteiner Jun 27, 2025 9:00am

Clock in front of the subway

Fierce Biotech

FDA 'on track' to meet all PDUFA dates, Marty Makary says

Jun 18, 2025 4:00am

sales sales increase

Teva forecasts $5B-plus in innovative drug sales by 2030

May 30, 2025 7:20am

blood disorders genetic disorders rare disease

Amid ongoing launches, Novo eyes rare disease leadership

Mar 7, 2025 9:20am

Photo of a chain being held together by a piece of rope

Atara hit with cell therapy clinical hold after FDA inspection

Jan 21, 2025 9:59am

Fierce 50

Fierce 50 of 2024

Sep 9, 2024 5:02am